DOCSLIB.ORG

SOX4 Is Activated by C-MYC in Prostate Cancer

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
SOX4 Is Activated by C-MYC in Prostate Cancer Medical Oncology (2019) 36:92 https://doi.org/10.1007/s12032-019-1317-6 ORIGINAL PAPER SOX4 is activated by C‑MYC in prostate cancer Hongyan Dong1,2 · Jing Hu1 · Lin Wang3 · Mei Qi1 · Ning Lu1 · Xiao Tan2 · Muyi Yang1 · Xinnuo Bai4 · Xuemei Zhan2 · Bo Han1,5 Received: 26 July 2019 / Accepted: 12 September 2019 / Published online: 27 September 2019 © Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract Although MYC proto-oncogene (C-MYC) amplifcation has been consistently reported to be a potential marker for prostate cancer (PCa) progression and prognosis, the clinicopathological and prognostic signifcance of C-MYC protein expression remains controversial. Overexpression of SOX4 has been shown to play important roles in multiple cancers including PCa. However, the link between these two critical genetic aberrations is unclear. In the current study, we showed that C-MYC was overexpressed in 16.2% (17/105) of Chinese patients with localized PCa. Overexpression of C-MYC was signifcantly associated with high Gleason scores (P = 0.012) and high Ki67 labeling index (P = 0.005). C-MYC overexpression was cor- related with cancer-related mortality and suggested to be an unfavorable prognostic factor in Chinese PCa patients (P = 0.018). Overexpression of C-MYC is associated with SOX4 overexpression in PCa tissues. Notably, SOX4 is a direct target gene of C-MYC; C-MYC activates SOX4 expression via binding to its promoter. In addition, Co-IP analysis demonstrated a physi- cal interaction between C-MYC and SOX4 protein in PCa cells. Clinically, C-MYC+/SOX4+ characterized poor prognosis in a subset of PCa patients. In total, C-MYC overexpression may contribute to PCa progression by activating SOX4. Our fndings highlight an important role of C-MYC/SOX4 in PCa progression in a subset of PCa patients. Keywords Prostate cancer · C-MYC · SOX4 · Overexpression · Prognosis Introduction Prostate cancer (PCa) is a common, heterogeneous disease with marked variability in progression [1]. Currently, the established prognostic factors (Gleason score, pathological stage and serum PSA) cannot precisely distinguish indolent Electronic supplementary material The online version of this PCas from highly aggressive cancers [1, 2]. Thus, novel article (https ://doi.org/10.1007/s1203 2-019-1317-6) contains prognostic biomarkers are urgently needed for PCa diagno- supplementary material, which is available to authorized users. sis and management. * Bo Han C-MYC is a regulatory protein of transcription that regu- [email protected] lates multiple cellular processes including cell proliferation, cell-cycle progression, transcription, diferentiation, apop- 1 The Key Laboratory of Experimental Teratology, Ministry of Education and Department of Pathology, School of Basic tosis, and cellular motility [3]. C-MYC is overexpressed in Medical Sciences, Shandong University, Jinan 250012, large varieties of tumor types and plays an important role China in tumor initiation and progression [4]. In PCa, elevated 2 Department of Pathology, Linyi People’s Hospital, Linyi, C-MYC expression has been found in PCa tissues [5–7] China and is associated with biochemical recurrence after radical 3 Research Center for Medical Biotechnology, Shandong prostatectomy [7]. The overexpression of C-MYC, in many Academy of Medical Sciences, Jinan, China cases, is associated with somatic genetic alterations includ- 4 Department of Human Biology, University of Toronto, ing translocations and gene amplifcation [4]. C-MYC ampli- Toronto M5S3J6, Canada fcation has been consistently reported to be an independent 5 Department of Pathology, Shandong University Qilu potential marker for disease progression and prognosis in Hospital, Jinan, China Vol.:(0123456789)1 3 92 Page 2 of 11 Medical Oncology (2019) 36:92 PCa [8, 9]. However, the relationship of C-MYC overexpres- protocol was approved by the Institutional Review Board of sion and C-MYC amplifcation as well as its correlation with Medicine School of Shandong University. clinicopathological parameters, disease progression, and prognosis remains controversial [9–12]. Immunohistochemistry (IHC) The sex determining region Y-box 4 (SOX4) gene is a developmental regulatory protein of transcription involved Immunohistochemical staining was performed by the stand- in the regulation of many key cellular processes, including ardized labeled streptavidin biotin kit (Dako Cytomation, apoptosis, cell-cycle control, microRNA processing, dif- USA) according to the manufacturer’s instructions. The ferentiation, and growth factor signaling [13]. Large-scale slides were incubated with rabbit polyclonal anti-SOX4 gene expression studies have identifed the overexpression antibody (1:100 dilution, Abcam, UK), mouse monoclo- of the SOX4 gene in a variety of human cancers, including nal anti-C-MYC antibody (1:200 dilution, Abcam, UK), or prostate [14], breast [15], lung [16], and colon cancers [17]. mouse monoclonal anti-Ki67 (1:100 dilution, Dako, USA), SOX4 has been recognized as one of the 64 “cancer signa- and was blindedly evaluated by two pathologists (B.H. and ture” genes, suggesting that SOX4 plays a fundamental role H.Y.D.) independently. Sections with evaluation disagree- in tumorigenesis and tumor progression [18]. Previously, ment between the reviewers were re-reviewed until a con- we have reported that SOX4 may initiate a transcriptional sensus was reached. The scoring system to validate C-MYC, program that enables the epithelial–mesenchymal transi- SOX4, and Ki67 expression was described elsewhere [19]. tion (EMT) phenotype [19]. Tiwari et al. also reported that SOX4 is a master regulator of EMT by controlling EZH2 Fluorescence in situ hybridization (FISH) expression and epigenetic reprogramming [20, 21]. More importantly, SOX4 might contribute to metastasis by coop- FISH analysis of abnormalities in C-MYC gene copy was erating with other important oncogenes to promote PCa carried out with the C-MYC/CEP8 probe mix (Dako, metastasis [22, 23]. Most recently, we have demonstrated a Denmark) according to the manufacturer’s protocol, and link between SOX4 and ERG gene in the development of a the scoring system used was previously described [8]. A subset of PCa patients [22], and that SOX4 may serve as a minimum of 50 cancer cells under each visual feld were prognostic marker for Chinese PCa patients [19]. Therefore, recorded. Cases lacking tumor tissues in both two cores were these data highlight the role of SOX4 in PCa progression excluded, and cancer tissues with very weak or no signals and metastasis. were recorded as insufciently hybridized. Amplifcation of In this study, we show that SOX4 is a direct target of the C-MYC locus was defned as a C-MYC/CEP8 ratio of C-MYC. Clinically, the overexpression of C-MYC is sig- higher than 2.0. nifcantly associated with SOX4 expression and C-MYC+/ SOX4+ characterizes poor prognosis in a subset of PCa Cell lines and plasmids patients. Collectively, our data suggest a cooperative role of C-MYC and SOX4 in PCa. The HEK293T (CRL-3216) cell line and human PCa cell lines (LNCaP and VCaP) were obtained from American Type Culture Collection (Rockville, USA) and cultured according to the manufacturer’s recommendations. Materials and methods Cell transfection Patients and tissue microarray (TMA) construction The plasmids and siRNA were transfected into PCa A total of 126 PCa patients (Qilu cohort) diagnosed between cells by Lipofectamine 2000 (Invitrogen, Carlsbad, CA, 2007 and 2014 participated in our study. The frst cohort USA) according to the manufacturer’s instructions. The consisted of 105 men with localized PCas who have under- pcDNA3.3-C-MYC plasmid (Addgene plasmid #26818) gone radical prostatectomy as monotherapy. The follow- was obtained as a gift from Dr. Derrick Rossi at Harvard up data were available from 94 patients, ranging from 3 to Medical School. 115 months (mean 35 months). The second cohort included patients with CRPC treated by transurethral resection of RNA extraction and quantitative real‑time PCR the prostate to relieve symptomatic obstruction due to the (RT‑PCR) locally advanced disease (n = 21). The initial treatment for patients was either observation or surgery. Morphology was RNA extraction and RT-PCR were performed as previously validated by two pathologists (B. H. and H. Y. D.). Written described [19]. Total RNA was extracted with Trizol rea- informed consent was obtained from each patient. The study gents following the manufacturer’s instructions (Invitrogen). 1 3 Medical Oncology (2019) 36:92 Page 3 of 11 92 GAPDH was used as an internal loading control. The details CST, USA). Actin (1:1000, ZSGB-BIO, China) was used of the primers for each gene are listed in Supplementary as a loading control. Three independent experiments were Table 1. performed. Immunoprecipitations were performed with Protein A/G Western blot and co‑immunoprecipitation (Co‑IP) Agarose beads (Beyotime, China) to assess the interaction analysis between C-MYC and SOX4 according to manufacturer’s instructions. After harvesting the cells, the supernatants Western blot was carried out as previously described [19]. were incubated overnight at 4 °C with Protein G-Sepharose The membrane was incubated with primary antibodies for beads (Sigma) conjugated with rabbit anti-SOX4, anti-Flag, C-MYC (1:1000; CST, USA), SOX4 (1:1000; Abcam, UK), and anti-C-MYC antibody. The samples were then run E-cadherin (1:1000, CST, USA), and Vimentin (1:1000, through gradient SDS-polyacrylamide gels and transferred to membranes that were probed with anti-C-MYC or anti- SOX4 antibodies. Table 1 Association of clinicopathological variables and molecular biomarkers with C-MYC overexpression Chromatin immunoprecipitation assay (ChIP) Variables C-MYC protein expression P Negative and Moderate and ChIP assay was performed according to the manufacturer’s weak (/%) strong (/%) protocol (ChIP Assay Kit, Millipore, USA). The puri- fed chromatin was immunoprecipitated by 6 μg of mouse All cases 80 (84.2) 15 (15.8) monoclonal anti-C-MYC (Abcam, UK) or mouse anti-IgG Age (years) (Beyotime, China). The purifed chromatin was assessed by ≤ 65 14 (77.8) 4 (22.2) 0.474 RT-PCR.
Load more

Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Transcriptional Control of Tissue-Resident Memory T Cell Generation
    Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2019 © 2019 Filip Cvetkovski All rights reserved ABSTRACT Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Tissue-resident memory T cells (TRM) are a non-circulating subset of memory that are maintained at sites of pathogen entry and mediate optimal protection against reinfection. Lung TRM can be generated in response to respiratory infection or vaccination, however, the molecular pathways involved in CD4+TRM establishment have not been defined. Here, we performed transcriptional profiling of influenza-specific lung CD4+TRM following influenza infection to identify pathways implicated in CD4+TRM generation and homeostasis. Lung CD4+TRM displayed a unique transcriptional profile distinct from spleen memory, including up-regulation of a gene network induced by the transcription factor IRF4, a known regulator of effector T cell differentiation. In addition, the gene expression profile of lung CD4+TRM was enriched in gene sets previously described in tissue-resident regulatory T cells. Up-regulation of immunomodulatory molecules such as CTLA-4, PD-1, and ICOS, suggested a potential regulatory role for CD4+TRM in tissues. Using loss-of-function genetic experiments in mice, we demonstrate that IRF4 is required for the generation of lung-localized pathogen-specific effector CD4+T cells during acute influenza infection. Influenza-specific IRF4−/− T cells failed to fully express CD44, and maintained high levels of CD62L compared to wild type, suggesting a defect in complete differentiation into lung-tropic effector T cells.
    [Show full text]
  • SUPPLEMENTAL FIGURE LEGENDS Supplemental Figure S1. RBPJ
    Xie et al. SUPPLEMENTAL FIGURE LEGENDS Supplemental Figure S1. RBPJ correlates with BTIC marker expression. A-D. The TCGA GBM dataset was downloaded and correlations analyzed by R. RBPJ mRNA levels were highly correlated with (A) Olig2, (B) Sox2, (C) CD133, and (D) Sox4 levels. E. RBPJ is preferentially expressed in proneural glioblastomas. The glioblastoma TCGA dataset was interrogated for RBPJ mRNA expression segregated by transcriptional profile. The proneural tumors were further divided into G-CIMP (glioma CpG-island methylator phenotype) or non-G-CIMP. **, p < 0.01. ****, p < 0.0001. *****, p < 0.00001. Supplemental Figure S2. Targeting RBPJ induces BTIC apoptosis. A. 3691 BTICs were transduced with shCONT, shRBPJ-1, or shRBPJ-2. Lysates were prepared and immunoblotted with the indicated antibodies. shRNA-mediated knockdown of RBPJ was associated with increased cleaved (activated) PARP. B. 3691 BTICs were transduced with shCONT, shRBPJ-1, or shRBPJ-2. Apoptosis measured by Annexin V staining. Data are presented as mean ± SEM (two- way ANOVA; **, p < 0.01; n = 3). Supplemental Figure S3. Targeting RBPJ does not affect non-BTIC proliferation. Non-BTICs (Top, 3691; Bottom, 4121) were transduced with shCONT, shRBPJ-1, or shRBPJ-2. Cell proliferation was measured by CellTiter-Glo. 42 Xie et al. Supplemental Figure S4. RBPJ induces transcriptional profiles in BTICs distinct from Notch activation. A. In parallel experiments, 3691 BTICs were either treated with DAPT (at either 5 μM or 10 μM) vs. vehicle control (DMSO) or transduced with shRBPJ vs. shCONT. RNA-Seq was performed and the results displayed as a heat map with normalization to the relevant control.
    [Show full text]
  • Transcription Factor Gene Expression Profiling and Analysis of SOX Gene Family Transcription Factors in Human Limbal Epithelial
    Transcription factor gene expression profiling and analysis of SOX gene family transcription factors in human limbal epithelial progenitor cells Der Naturwissenschaftlichen Fakultät der Friedrich-Alexander-Universität Erlangen-Nürnberg zur Erlangung des Doktorgrades Dr. rer. nat. vorgelegt von Dr. med. Johannes Menzel-Severing aus Bonn Als Dissertation genehmigt von der Naturwissenschaftlichen Fakultät der Friedrich-Alexander-Universität Erlangen-Nürnberg Tag der mündlichen Prüfung: 7. Februar 2018 Vorsitzender des Promotionsorgans: Prof. Dr. Georg Kreimer Gutachter: Prof. Dr. Andreas Feigenspan Prof. Dr. Ursula Schlötzer-Schrehardt 1 INDEX 1. ABSTRACTS Page 1.1. Abstract in English 4 1.2. Zusammenfassung auf Deutsch 7 2. INTRODUCTION 2.1. Anatomy and histology of the cornea and the corneal surface 11 2.2. Homeostasis of corneal epithelium and the limbal stem cell paradigm 13 2.3. The limbal stem cell niche 15 2.4. Cell therapeutic strategies in ocular surface disease 17 2.5. Alternative cell sources for transplantation to the corneal surface 18 2.6. Transcription factors in cell differentiation and reprogramming 21 2.7. Transcription factors in limbal epithelial cells 22 2.8. Research question 25 3. MATERIALS AND METHODS 3.1. Human donor corneas 27 3.2. Laser Capture Microdissection (LCM) 28 3.3. RNA amplification and RT2 profiler PCR arrays 29 3.4. Real-time PCR analysis 33 3.5. Immunohistochemistry 34 3.6. Limbal epithelial cell culture 38 3.7. Transcription-factor knockdown/overexpression in vitro 39 3.8. Proliferation assay 40 3.9. Western blot 40 3.10. Statistical analysis 41 2 4. RESULTS 4.1. Quality control of LCM-isolated and amplified RNA 42 4.2.
    [Show full text]
  • SOX4 Expression in Bladder Carcinoma: Clinical Aspects and in Vitro Functional Characterization
    Research Article SOX4 Expression in Bladder Carcinoma: Clinical Aspects and In vitro Functional Characterization Mads Aaboe,1 Karin Birkenkamp-Demtroder,1 Carsten Wiuf,1,3 Flemming Brandt Sørensen,4 Thomas Thykjaer,1 Guido Sauter,5 Klaus Møller-Ernst Jensen,2 Lars Dyrskjøt,1 and Torben Ørntoft1 1Molecular Diagnostic Laboratory, Department of Clinical Biochemistry, and 2Department of Urology, Aarhus University Hospital/Skejby Sygehus, Aarhus N, Denmark; 3Bioinformatics Research Center, University of Aarhus; 4Institute of Pathology, Aarhus University Hospital, Aarhus Sygehus, Aarhus C, Denmark; and 5Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Abstract shown to be involved in a range of developmental processes. The SOX4À/À phenotype in mouse results in death during embryo- The human transcription factor SOX4 was 5-fold up-regulated in bladder tumors compared with normal tissue based on genesis due to lack of normal heart development, which results in whole-genome expression profiling of 166 clinical bladder circulatory failure (6, 7). Furthermore, other studies have shown tumor samples and 27 normal urothelium samples.Using a that SOX4 is expressed in hormone-responsive tissues of the SOX4-specific antibody, we found that the cancer cells reproductive system in mouse, as well as in brain and T- and B-cell expressed the SOX4 protein and, thus, did an evaluation of lymphocytes (8, 9), and may play a role in osteoblastic differenti- SOX4 protein expression in 2,360 bladder tumors using a ation (10). tissue microarray with clinical annotation.We found a SOX4 binds to the 7-bp DNA-motif AACAAAG through its high mobility group domain and thereby transcriptionally activates correlation (P < 0.05) between strong SOX4 expression and target genes (9, 11).
    [Show full text]
  • ID1 Mediates Escape from TGF-Β Tumor Suppression in Pancreatic Cancer
    Author Manuscript Published OnlineFirst on October 3, 2019; DOI: 10.1158/2159-8290.CD-19-0529 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. ID1 mediates escape from TGF-β tumor suppression in pancreatic cancer Yun-Han Huang1,2,3, Jing Hu1, Fei Chen1, Nicolas Lecomte4, Harihar Basnet1, Charles J. David1,10, Matthew D. Witkin5, Peter J. Allen6, Steven D. Leach4,6,7,9, Travis J. Hollmann7,8, Christine A. Iacobuzio-Donahue4,7,8, and Joan Massagué1* 1Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065 2Weill Cornell/Sloan Kettering/Rockefeller Tri-Institutional MD-PhD Program, New York, NY 10065 3Gerstner Sloan Kettering Graduate School of Biomedical Sciences, New York, NY 10065 4The David M. Rubinstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065 5Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065 6Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065 7Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065 8Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065 9Present address: Department of Molecular and Systems Biology, Dartmouth Geisel School of Medicine, 1 Rope Ferry Road, Hanover, NH 03755-1404 10Present address: Tsinghua University School of Medicine, Department of Basic Sciences, Medical Sciences Building D106, Haidian District, Beijing, China, 100084 Running title: ID1 mediates escape from TGF-β tumor suppression in PDA Keywords: TGF-β, pancreatic cancer, ID1, tumor suppression, EMT Financial support: National Cancer Institute grants R01-CA34610 (JM) and P30-CA008748 (MSKCC), and Predoctoral Fellowship F30-CA203238 (YH).
    [Show full text]
  • The Tumor Suppressor HHEX Inhibits Axon Growth When Prematurely Expressed in Developing Central Nervous System Neurons
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by epublications@Marquette Marquette University e-Publications@Marquette Biological Sciences Faculty Research and Biological Sciences, Department of Publications 9-1-2015 The umorT Suppressor HHEX Inhibits Axon Growth when Prematurely Expressed in Developing Central Nervous System Neurons Matthew .T Simpson Marquette University Ishwariya Venkatesh Marquette University Ben L. Callif Marquette University Laura K. Thiel Marquette University Denise M. Coley Marquette University See next page for additional authors Accepted version. Molecular and Cellular Neuroscience, Vol 68 )September 2015): 272-283. DOI. © 2015 Elsevier Inc. Used with permission. NOTICE: this is the author’s version of a work that was accepted for publication in Molecular and Cellular Neuroscience. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Molecular and Cellular Neuroscience, Vol 68 )September 2015): 272-283. DOI. Authors Matthew T. Simpson, Ishwariya Venkatesh, Ben L. Callif, Laura K. Thiel, Denise M. Coley, Kristen N. Winsor, Zimei Wang, Audra A. Kramer, Jessica K. Lerch, and Murray G. Blackmore This article is available at e-Publications@Marquette: https://epublications.marquette.edu/bio_fac/515 NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be accessed by following the link in the citation at the bottom of the page. The Tumor Suppressor HHEX Inhibits Axon Growth When Prematurely Expressed in Developing Central Nervous System Neurons Matthew T.
    [Show full text]
  • Genetic Determinants and Epigenetic Effects of Pioneer-Factor Occupancy
    ARTICLES https://doi.org/10.1038/s41588-017-0034-3 Genetic determinants and epigenetic effects of pioneer-factor occupancy Julie Donaghey1,2, Sudhir Thakurela 1,2, Jocelyn Charlton2,3, Jennifer S. Chen2, Zachary D. Smith1,2, Hongcang Gu1, Ramona Pop2, Kendell Clement1,2, Elena K. Stamenova1, Rahul Karnik1,2, David R. Kelley 2, Casey A. Gifford1,2,5, Davide Cacchiarelli1,2,6, John L. Rinn1,2,7, Andreas Gnirke1, Michael J. Ziller4 and Alexander Meissner 1,2,3* Transcription factors (TFs) direct developmental transitions by binding to target DNA sequences, influencing gene expres- sion and establishing complex gene-regultory networks. To systematically determine the molecular components that enable or constrain TF activity, we investigated the genomic occupancy of FOXA2, GATA4 and OCT4 in several cell types. Despite their classification as pioneer factors, all three TFs exhibit cell-type-specific binding, even when supraphysiologically and ectopically expressed. However, FOXA2 and GATA4 can be distinguished by low enrichment at loci that are highly occupied by these fac- tors in alternative cell types. We find that expression of additional cofactors increases enrichment at a subset of these sites. Finally, FOXA2 occupancy and changes to DNA accessibility can occur in G1-arrested cells, but subsequent loss of DNA meth- ylation requires DNA replication. rganismal development is orchestrated by the selective use the regulatory capabilities of the presumed pioneer TFs FOXA2, and distinctive interpretation of identical genetic material GATA4 and OCT4, which are frequently studied in development Oin each cell. During this process, TFs coordinate protein and used in cellular reprogramming. complexes at associated promoter and distal enhancer elements to modulate gene expression.
    [Show full text]
  • Identification of Differentially Expressed and Developmentally
    Oncogene (2004) 23, 3444–3453 & 2004 Nature Publishing Group All rights reserved 0950-9232/04 $25.00 www.nature.com/onc Identification of differentially expressed and developmentally regulated genes in medulloblastoma using suppression subtraction hybridization Naoki Yokota1,2,3, Todd G Mainprize1,2, Michael D Taylor1,2, Tomohiko Kohata1,2, Michael Loreto1,2, Shigeo Ueda1,2, Wieslaw Dura4, Wiesia Grajkowska4, John S Kuo1,2 and James T Rutka1,2,* 1The Arthur and Sonia Labatt Brain Tumor Research Centre, The University of Toronto, Toronto, Ontario, Canada; 2The Division of Neurosurgery, The University of Toronto, Toronto, Ontario, Canada; 3The Department of Neurosurgery, Hamamatsu University School of Medicine, Hamamatsu, Japan; 4Department of Pathology, University of Warsaw, Warsaw, Poland To increase our understanding of the molecular pathogen- Keywords: medulloblastoma; developmentally regulated esis of medulloblastoma (MB), we utilized the technique of gene; differentially expressed gene; subtractive suppres- suppression subtractive hybridization (SSH) to identify sion hybridization; cerebellum; external granule cell genes that are dysregulated in MB when compared to cerebellum. SSH-enriched cDNA libraries from both human and Ptch þ /À heterozygous murine MBs were generated by subtracting common cDNAs from corre- Introduction sponding non-neoplastic cerebellum. For the human classic MB library, total human cerebellar RNA was Despite the paucity of knowledge regarding the mole- þ /À used as control tissue; for the Ptch heterozygous MB, cular oncogenesis of most human brain tumors, our þ /À non-neoplastic cerebellum from an unaffected Ptch understanding of the molecular pathways causing littermate was used as the control. Through differential medulloblastoma (MB), the most common malignant screening of these libraries, over 100 upregulated tumor brain tumor in children, has advanced considerably.
    [Show full text]
  • Oncogenic Potential of the Dual-Function Protein MEX3A
    biology Review Oncogenic Potential of the Dual-Function Protein MEX3A Marcell Lederer 1,*, Simon Müller 1, Markus Glaß 1 , Nadine Bley 1, Christian Ihling 2, Andrea Sinz 2 and Stefan Hüttelmaier 1 1 Charles Tanford Protein Center, Faculty of Medicine, Institute of Molecular Medicine, Section for Molecular Cell Biology, Martin Luther University Halle-Wittenberg, Kurt-Mothes-Str. 3a, 06120 Halle, Germany; [email protected] (S.M.).; [email protected] (M.G.).; [email protected] (N.B.); [email protected] (S.H.) 2 Center for Structural Mass Spectrometry, Department of Pharmaceutical Chemistry & Bioanalytics, Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Kurt-Mothes-Str. 3, 06120 Halle (Saale), Germany; [email protected] (C.I.); [email protected] (A.S.) * Correspondence: [email protected] Simple Summary: RNA-binding proteins (RBPs) are involved in the post-transcriptional control of gene expression, modulating the splicing, turnover, subcellular sorting and translation of (m)RNAs. Dysregulation of RBPs, for instance, by deregulated expression in cancer, disturbs key cellular processes such as proliferation, cell cycle progression or migration. Accordingly, RBPs contribute to tumorigenesis. Members of the human MEX3 protein family harbor RNA-binding capacity and E3 ligase activity. Thus, they presumably combine post-transcriptional and post-translational regulatory mechanisms. In this review, we discuss recent studies to emphasize emerging evidence for a pivotal role of the MEX3 protein family, in particular MEX3A, in human cancer. Citation: Lederer, M.; Müller, S.; Glaß, M.; Bley, N.; Ihling, C.; Sinz, A.; Abstract: MEX3A belongs to the MEX3 (Muscle EXcess) protein family consisting of four members Hüttelmaier, S.
    [Show full text]
  • Microrna Expression and Activity in T-Cell Acute Lymphoblastic Leukemia
    www.impactjournals.com/oncotarget/ Oncotarget, 2018, Vol. 9, (No. 4), pp: 5445-5458 Review MicroRNA expression and activity in T-cell acute lymphoblastic leukemia Fang Ye1 1Department of Hematology, Beijing Chuiyangliu Hospital Affiliated to Tsinghua University, Beijing, China Correspondence to: Fang Ye, email: [email protected] Keywords: MicroRNA; T-ALL; NOTCH1 Received: October 27, 2017 Accepted: December 01, 2017 Published: December 20, 2017 Copyright: Ye. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT T-cell acute lymphoblastic leukemia (T-ALL) is a lymphoid malignancy caused by the oncogenic transformation of immature T-cell progenitors. Many biologically relevant genetic and epigenetic alterations have been identified as driving factors for this transformation. Recently, microRNAs (miRNAs) have been shown to influence various leukemias, including T-ALL. Aberrant expression of miRNAs can function as either oncogenes or tumor suppressors in T-ALL through the regulation of cell migration, invasion, proliferation, apoptosis, and chemoresistance. This occurs by targeting key signaling pathways or transcriptional factors that play a critical role in T-ALL pathology and progression. Different miRNA expression profiles have been linked to specific genetic subtypes of human T-ALL. Furthermore, miRNAs can also act as independent prognostic factors to predict clinical outcomes for T-ALL patients. In the current review, we will focus on the role of miRNAs in the development and progression of T-ALL. INTRODUCTION immunophenotypes that reflect immature thymocytes arresting at different stages of differentiation [7].
    [Show full text]
  • Single Cell Transcriptomic Analysis of Human Pluripotent Stem Cell Chondrogenesis
    ARTICLE https://doi.org/10.1038/s41467-020-20598-y OPEN Single cell transcriptomic analysis of human pluripotent stem cell chondrogenesis Chia-Lung Wu1,2,5,6, Amanda Dicks1,2,3,6, Nancy Steward1,2, Ruhang Tang1,2, Dakota B. Katz1,2,3, ✉ Yun-Rak Choi1,2,4 & Farshid Guilak 1,2,3 The therapeutic application of human induced pluripotent stem cells (hiPSCs) for cartilage regeneration is largely hindered by the low yield of chondrocytes accompanied by unpre- 1234567890():,; dictable and heterogeneous off-target differentiation of cells during chondrogenesis. Here, we combine bulk RNA sequencing, single cell RNA sequencing, and bioinformatic analyses, including weighted gene co-expression analysis (WGCNA), to investigate the gene reg- ulatory networks regulating hiPSC differentiation under chondrogenic conditions. We identify specific WNTs and MITF as hub genes governing the generation of off-target differentiation into neural cells and melanocytes during hiPSC chondrogenesis. With heterocellular signaling models, we further show that WNT signaling produced by off-target cells is responsible for inducing chondrocyte hypertrophy. By targeting WNTs and MITF, we eliminate these cell lineages, significantly enhancing the yield and homogeneity of hiPSC-derived chondrocytes. Collectively, our findings identify the trajectories and molecular mechanisms governing cell fate decision in hiPSC chondrogenesis, as well as dynamic transcriptome profiles orches- trating chondrocyte proliferation and differentiation. 1 Dept. of Orthopaedic Surgery, Washington University in Saint Louis, St. Louis, MO 63110, USA. 2 Shriners Hospitals for Children—St. Louis, St. Louis, MO 63110, USA. 3 Dept. of Biomedical Engineering, Washington University in Saint Louis, St. Louis, MO 63110, USA. 4 Dept. of Orthopaedic Surgery, Yonsei University, Seoul, South Korea.
    [Show full text]